BackDiebold Nixdorf Overview
Diebold Nixdorf Inc - Ordinary Shares- New

Diebold Nixdorf P/E Ratio

Latest P/E ratio for Diebold Nixdorf: 23.66 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

23.66

P/E Ratio

23.66

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

Average P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Diebold Nixdorf (DBD) FAQ

Diebold Nixdorf (DBD) currently reports a P/E ratio of 23.66. That is below the Technology sector average of 34.62. Use the charts on this page to explore Diebold Nixdorf's P/E ratio history and peer comparisons.

Diebold Nixdorf's P/E ratio of 23.66 is lower than the Technology sector average of 34.62. That is roughly 31.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Diebold Nixdorf's market price to a fundamental measure such as earnings, sales, or book value. At 23.66, DBD can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 23.66, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 34.62. From there, open related valuation or income-statement pages for Diebold Nixdorf, and consider following DBD for alerts when major investors trade the stock.

Diebold Nixdorf is classified in the Technology sector. On P/E ratio, it currently shows 23.66 versus a sector average near 34.62. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing DBD with unrelated industries.